March 1-2, 2017 | Scottsdale, AZ
As health systems continue to grow and merge to form larger Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with, and sell to, these evolving systems to ensure product success. With conflict of interest policies in place and restricted access to physicians, manufacturers are changing their sales approach to better reach and engage these new customers.
CBI’s Partnering with IDNs BioPharma Strategy Summit brings together manufacturers and IDNs to discuss tow to create a mutually beneficial partnership for continual care coordination, strategic product management and improved access.
Do Not Miss These Insights:
- Engaging panels discussing the IDN model of patient care coordination and what it can do to improve the patient experience on behalf of the provider, manufacturer, payer and other stakeholders
- A luminary showcase around the pros and cons of national specialty pharmacies versus IDN specialty pharmacies
- Changes in the hospital reimbursement model, focused on quality tied to outcomes measures
- Effective ways manufacturers can partner with health systems and support their goals
- And More!
Visit www.cbinet.com/IDNStrategySpring for more information. Drug Channels subscribers will save $400 off the standard registration rate when they use discount code XTG398.*
*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.